Underdosing of opioid analgesia is a significant problem in ... as an acceptable starting dose for treating patients with acute pain. Unfortunately, many physicians start much lower.

In 1986 the World Health Organization (WHO) published analgesic guidelines for the treatment of cancer pain based on a three-step ladder and practical recommendations. These guidelines serve as an ...

The new oral medication has been approved for the treatment of acute pain of any kind ... would be placed in the third tier of the WHO analgesic ladder, at the same level as potent opioids ...

This new drug is a non-opioid analgesic, the first of its kind, designed to treat moderate to severe acute pain in adults.

On January 30th, in a landmark decision that could reshape the way acute pain is treated in the United States, the FDA approved suzetrigine (brand name, Journavx), a first-in-class non-opioid ...

Among patients with advanced cancer, individualized opioid management was effective for pain control without increasing doses.

In the wake of the opioid crisis and the new limitations on prescribing them, scientists and companies are chasing novel approaches to acute and chronic pain. A new crop of drugs is coming to the ...